Biocon Q1 result: Net profit falls 11% to Rs 148.9 crore
Biocon Ltd on Thursday reported an 11 per cent decline in consolidated net profit at Rs 148.9 crore in the first quarter ended June 30, 2023.
Biocon Ltd on Thursday reported an 11 per cent decline in consolidated net profit at Rs 148.9 crore in the first quarter ended June 30, 2023.
The company had posted a consolidated net profit of Rs 167.4 crore in the same quarter last fiscal, Biocon Ltd said in a regulatory filing.
Consolidated revenue from operations during the quarter under review stood at Rs 3,422.6 crore as compared to Rs 2,139.5 crore in the corresponding period a year ago, it added. Total expenses were higher at Rs 3,299.2 crore in the first quarter as against Rs 1,977.5 crore in the year-ago period, the company said.
On a standalone basis, Biocon said its net profit was at Rs 46.6 crore, up from Rs 14.9 crore in the same quarter previous fiscal. Standalone revenue from operations stood at Rs 513.2 crore as compared to Rs 441.7 crore in the year-ago quarter, the filing said.
The company said its board approved the appointment of Nicholas Robert Haggar as an Additional Non-Executive, Independent Director subject to registration of his name in the
Independent Director's databank maintained by the Indian Institute of Corporate Affairs (IICA) and accordingly, his appointment on the board will be effective from such date.
Catch the latest stock market updates here. For all other news related to business, politics, tech, sports, and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Rs 2,000 Monthly SIP: Can one achieve Rs 3.18 crore corpus by investing Rs 2,000 monthly? If yes, in how many years
Gold now down nearly Rs 6200/10 gm from all-time highs hit in October end: Should you wait or bet on opportunity?
Stocks to buy for 15 days: Analysts bullish on these 2 largecap, 2 midcap, 1 smallcap scrips - Check targets
09:58 PM IST